Series B - Kymera Therapeutics
Investment Firm
Overview
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Announced Date
Nov 13, 2018
Funding Type
Series B
Highlights
N/A
Location
N/A
Social
N/A
Investor Lead
Bessemer Venture Partners
Bessemer Venture Partners is a early_stage_venture and late_stage_venture firm.
6 Dimensions Capital
6 Dimensions Capital is a early_stage_venture and late_stage_venture and seed and venture firm.
Pfizer Venture Investments
Pfizer Venture Investments is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.
Participant Investors
10
Round Details and Background
Kymera Therapeutics raised $65000000 on 2018-11-13 in Series B
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 28, 2021 | - | 257.0M | ||
| Aug 19, 2022 | 6 | - | 150.0M | |
| Jan 05, 2024 | - | 275.0M | ||
| Oct 30, 2017 | 3 | - | 30.0M |
Recent Activity
There is no recent news or activity for this profile.